Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name LXH 254
Trade Name
Synonyms LXH254|LXH-254
Drug Descriptions

LXH 254 is a RAF inhibitor that selectively inhibits monomeric and dimerized BRAF and CRAF, which may lead to anti-tumor activity in RAF-mutant tumors and better tolerability (AACR Annual Meeting 2019, Abstract LB-114, PMID: 31059256).

DrugClasses BRAF Inhibitor 21 CRAF Inhibitor 11
CAS Registry Number 1800398-38-2
NCIT ID C125003


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Dabrafenib + LTT462 + LXH 254 Dabrafenib LTT462 LXH 254 0 1
Dabrafenib + LXH 254 + Trametinib Dabrafenib LXH 254 Trametinib 2 0
LTT462 + LXH 254 LTT462 LXH 254 4 2
LXH 254 LXH 254 8 1
LXH 254 + Nazartinib LXH 254 Nazartinib 0 1
LXH 254 + Ribociclib LXH 254 Ribociclib 0 1
LXH 254 + Spartalizumab LXH 254 Spartalizumab 0 1
LXH 254 + Trametinib LXH 254 Trametinib 2 1

Additional content available in CKB BOOST